Copeland Capital Management’s NRC Health Common Stock NRC Stock Holding History

Copeland Capital Management’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78K	Sell	3,616 -118	-3%	-$2.19K	﹤0.01%	205
2026 Q1	$63.4K	Buy	3,734 +271	+8%	+$4.61K	﹤0.01%	214
2025 Q4	$65K	Buy	+3,463	New	+$52.3K	﹤0.01%	190
2022 Q4	–	Sell	-944	Closed	-$38K	–	291
2022 Q3	$38K	Buy	944 +13	+1%	+$481	﹤0.01%	161
2022 Q2	$36K	Buy	931 +34	+4%	+$1.23K	﹤0.01%	169
2022 Q1	$36K	Buy	897 +14	+2%	+$548	﹤0.01%	172
2021 Q4	$37K	Buy	883 +191	+28%	+$8.3K	﹤0.01%	170
2021 Q3	$29K	Hold	692	–	–	﹤0.01%	184
2021 Q2	$32K	Buy	+692	New	+$32.9K	﹤0.01%	176
2020 Q2	–	Sell	-391	Closed	-$18K	–	286
2020 Q1	$18K	Buy	391 +53	+16%	+$3.18K	﹤0.01%	165
2019 Q4	$22K	Hold	338	–	–	﹤0.01%	163
2019 Q3	$20K	Sell	338 -208	-38%	-$12.9K	﹤0.01%	162
2019 Q2	$31K	Buy	546 +193	+55%	+$8.93K	﹤0.01%	158
2019 Q1	$14K	Buy	353 +12	+4%	+$470	﹤0.01%	187
2018 Q4	$13K	Buy	+341	New	+$13.1K	﹤0.01%	175

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Copeland Capital Management's NRC Position: Q2 2026 in Review

Copeland Capital Management reduced its NRC Health Common Stock (NRC) stake by 3.2% in Q2 2026, selling an estimated $2.19K and leaving 3,616 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #205.

Copeland Capital Management first reported a position in NRC in Q4 2018 and has held it in 15 quarters since. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

Copeland Capital Management held 3,616 shares of NRC Health Common Stock worth $78K as of Q2 2026.
Copeland Capital Management sold 118 NRC Health Common Stock shares in Q2 2026, an estimated $2.19K.
NRC Health Common Stock made up ﹤0.01% of Copeland Capital Management's portfolio in Q2 2026, its #205 holding.
Copeland Capital Management first reported a position in NRC Health Common Stock in Q4 2018 and has held it in 15 quarters since.
124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Copeland Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.